Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.11.10.686309

Unilateral striatal deep brain stimulation improves cognitive control

Sachse, E. M.·Dastin-van Rijn, E. M.·Bennek, J. P.·Buccini, M. C.·Mensinger, M. E.·Iacobucci, F. A.·Reimer, A. E.·Widge, A. S.
View original source ↗Export metadata ↓

Abstract

Deep brain stimulation (DBS) of the ventral capsule/ventral striatum (VCVS) can treat obsessive-compulsive disorder (OCD) and other psychiatric conditions. Yet, optimizing its clinical efficacy is a major challenge, often hindered by incomplete knowledge of how stimulation parameters and targets affect neural activity and behavior. VCVS DBS is thought to work in part by improving cognitive control, an important decision-making component that is impaired in OCD and other illnesses. The magnitude of this cognitive control enhancement was shown to be lateralized, with right-unilateral stimulation being the most effective. Prior work developed a preclinical model of VCVS DBS by leveraging the cognitive control construct, which can be measured in humans and rodents and is modulated by analogous brain circuits. However, this work did not address laterality effects observed in humans or examine left/right stimulation differences. These effects may be critical for maximizing therapeutic benefit while avoiding aversive outcomes. This study aimed to investigate lateralization in the rodent model, where bilateral stimulation of the mid-striatum was previously shown to improve cognitive control. Right and left-unilateral stimulation reduced response times without changing accuracy, replicating the cognitive control improvement from bilateral stimulation. With computational modeling, we show that bilateral and unilateral stimulation modifies the same decision-making variables to drive this behavior change. We also establish that females have the same cognitive control improvement from stimulation as males. These findings increase our understanding of cognitive control circuits and strengthen the validity of the rodent model as a translational platform to study VCVS DBSs therapeutic mechanisms. Significance StatementHere, we demonstrate that stimulating just one side of the brain (e.g. unilaterally) can be as effective as bilateral stimulation for improving cognitive control, the ability to adjust thoughts and decisions in response to environmental changes. These findings in rodents match results from prior human deep brain stimulation (DBS) studies, highlighting the validity of this preclinical model to study DBSs therapeutic mechanisms. We hypothesize that unilateral stimulation may be preferable to maximize cognitive benefits without causing off-target effects, while also reducing surgical invasiveness. Further, we demonstrate that females have the same cognitive control improvement from stimulation as males. Overall, this work answers important outstanding clinical questions regarding laterality and sex in DBS therapies for psychiatric illnesses.

Source connections

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sachse, E. M., Dastin-van Rijn, E. M., Bennek, J. P., Buccini, M. C., Mensinger, M. E., Iacobucci, F. A., Reimer, A. E., Widge, A. S.. 2025-11-12. Unilateral striatal deep brain stimulation improves cognitive control. https://doi.org/10.1101/2025.11.10.686309

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗
bioRxiv2026

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗
bioRxiv2026

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗